Browse views: by Year, by Function, by GLF, by Subfunction, by Conference, by Journal

Expression of Recombinant Human Flavin Monooxygenase and application for N-oxidation of Moclobemide

Hanlon, Steven, Camattari, Andrea, Abad, Sandra, Glieder, Anton, Kittelmann, Matthias, Luetz, Stephan, Wirz, Beat and Winkler, Margit (2012) Expression of Recombinant Human Flavin Monooxygenase and application for N-oxidation of Moclobemide. Chemical communications. ISSN 1359-7349

Abstract

Rec. h. flavine containing monooxygenases (FMOs), isoforms 1-5, were cloned and expressed in E. coli BL21. Highest activity (methimazole oxidation) of solubilized enzyme was obtained with the FMO3 construct in an NADPH depletion assay. Moclobemide, a MAO-inhibitor marketed by Roche, was applied as the substrate in whole cell biotransformation assays. Citrate and NADP+ were required for effective bioconversion with FMO3 containing E. coli cells. In a whole cell biotransformation on one L scale with rec h FMO3 and 40 mg of moclobemide 81 % conversion to the N-oxide was achieved. The product was isolated from the reaction mixture and its structure confirmed by MS and NMR spectroscopy (poduct isolation and structure elucidation still ongoing).

Item Type: Article
Related URLs:
Additional Information: Collaboration with Roche AG, Basel and TU-Graz in the project "Non-CYP-Metabolizing Enzymes (NCME)" in the frame of the competence centre "ACIB - Austrian Research Centre of Industrial Biotechnology"
Keywords: Flavine containing monooxygenase, heterologous expression, biocatalysis, biotransformation, N-oxidation, moclobemide
Related URLs:
Date Deposited: 13 Oct 2015 13:14
Last Modified: 13 Oct 2015 13:14
URI: https://oak.novartis.com/id/eprint/6282

Search

Email Alerts

Register with OAK to receive email alerts for saved searches.